Christopher Mahoney

Christopher Mahoney has worked in the biotech industry since 2012. Christopher began as an Associate Scientist at Agios Pharmaceuticals, where they worked until 2019. In 2019, they joined MOMA Therapeutics as a Senior Scientist and was later promoted to Senior Scientist II. That same year, they also began working as a Consultant at Third Rock Ventures.

Christopher Mahoney attended UMass Amherst from 2001 to 2006.